Haemoctin 250 I.E.
Haemoctin 250 I.E. is a medicine authorised by Swissmedic under authorisation number 60094. The authorisation holder is Biotest (Schweiz) AG. The medicinal product code is Blood products and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 19 August 2010 and the authorisation is valid without a time limit. ATC code B02BD02 places the medicine in the group Antihemorrhagics.
| Authorisation number | 60094 |
|---|---|
| Name | Haemoctin 250 I.E. |
| Full name | Haemoctin 250 I.E., Pulver und Lösungsmittel zur Herstellung einer Injektionslösung |
| Authorisation holder | Biotest (Schweiz) AG |
| Medicinal product code | Blood products |
| Dispensing category | B · Prescription only |
| ATC code | B02BD02 |
| First authorisation | 19 August 2010 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Haemoctin 250 I.E., Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | B | 19 August 2010 |
| 2 | Haemoctin 500 I.E., Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | B | 19 August 2010 |
| 3 | Haemoctin 1000 I.E., Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | B | 19 August 2010 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 4 | 1 + 1 | Durchstechflasche(n) | B02BD02 | 06.01.1. | B |
| 7 | 1 + 1 | Durchstechflasche(n) | B02BD02 | 06.01.1. | B |
| 8 | 1 + 1 | Durchstechflasche(n) | B02BD02 | 06.01.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Haemoctin 250 I.E. authorised in Switzerland?
Yes. Haemoctin 250 I.E. is authorised by Swissmedic under authorisation number 60094, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Haemoctin 250 I.E. have?
Haemoctin 250 I.E. is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Haemoctin 250 I.E.?
The authorisation holder is Biotest (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.